Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 5017-5022, October 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coste, A. d. L.
Right arrow Articles by Perret, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coste, A. d. L.
Right arrow Articles by Perret, C.
[Cancer Research 59, 5017-5022, October 1, 1999]
© 1999 American Association for Cancer Research

Tumor Biology

Paradoxical Inhibition of c-myc-induced Carcinogenesis by Bcl-2 in Transgenic Mice1

Alix de La Coste, Alexandre Mignon2, Monique Fabre2, Emmanuelle Gilbert, Arlette Porteu, Terry Van Dyke, Axel Kahn and Christine Perret3

Institut National de la Santé et de la Recherche, U129, ICGM, Université Paris V René Descartes, 75014 Paris, France [A. d. L. C., A. M., E. G., A. P., A. K., C. P.]; Hôpital du Kremlin Bicêtre, Service d’Anatomopathologie du Pr. Bedossa, 94275 Le Kremlin-Bicecirc;tre, France [M. F.]; and Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27299 [T. V. D.]

Here, we investigated changes in apoptosis during tumor progression by analyzing the effect of coexpressing various antiapoptotic genes on the multistage process of c-myc-induced hepatocarcinogenesis in transgenic mice. Whereas continuous c-myc gene overexpression in the liver led to cellular hepatocarcinoma, the coexpression of the bcl-2 gene inhibited the emergence of liver tumors, by inhibiting a pretumoral phase characterized by increased proliferation and apoptosis. This antioncogenic effect was specific to Bcl-2 and was not shared by other antiapoptotic genes such as bcl-xL and a dominant negative form of p53. Thus, we have shown that Bcl-2 can have a tumor suppressor effect in vivo on c-myc-induced hepatocarcinogenesis during the emergence of neoplastic foci.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
Y. Janumyan, Q. Cui, L. Yan, C. G. Sansam, M. Valentin, and E. Yang
G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation
J. Biol. Chem., December 5, 2008; 283(49): 34108 - 34120.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. I. van de Wetering and C. M. Knudson
Chromosomal Instability and Supernumerary Centrosomes Represent Precursor Defects in a Mouse Model of T-Cell Lymphoma
Cancer Res., September 1, 2007; 67(17): 8081 - 8088.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Bailly-Maitre, E. Bard-Chapeau, F. Luciano, N. Droin, J.-M. Bruey, B. Faustin, C. Kress, J. M. Zapata, and J. C. Reed
Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration
Cancer Res., February 15, 2007; 67(4): 1442 - 1450.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Bai, H.-M. Ni, X. Chen, D. DiFrancesca, and X.-M. Yin
Deletion of Bid Impedes Cell Proliferation and Hepatic Carcinogenesis
Am. J. Pathol., May 1, 2005; 166(5): 1523 - 1532.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. H. Pierce, M. E. Vail, L. Ralph, J. S. Campbell, and N. Fausto
Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci
Am. J. Pathol., May 1, 2002; 160(5): 1555 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Vrana, C. K. Bieszczad, E. S. Cleaveland, Y. Ma, J. P. Park, T. K. Mohandas, and R. W. Craig
An MCL1-overexpressing Burkitt Lymphoma Subline Exhibits Enhanced Survival on Exposure to Serum Deprivation, Topoisomerase Inhibitors, or Staurosporine but Remains Sensitive to 1-{beta}-D-Arabinofuranosylcytosine
Cancer Res., February 1, 2002; 62(3): 892 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Cadoret, C. Ovejero, S. Saadi-Kheddouci, E. Souil, M. Fabre, B. Romagnolo, A. Kahn, and C. Perret
Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of {beta}-Catenin
Cancer Res., April 1, 2001; 61(8): 3245 - 3249.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. E. Vail, R. H. Pierce, and N. Fausto
Bcl-2 Delays and Alters Hepatic Carcinogenesis Induced by Transforming Growth Factor {{alpha}}
Cancer Res., January 1, 2001; 61(2): 594 - 601.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
C. M. Knudson, G. M. Johnson, Y. Lin, and S. J. Korsmeyer
Bax Accelerates Tumorigenesis in p53-deficient Mice
Cancer Res., January 1, 2001; 61(2): 659 - 665.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
C. Mitchell, A. Mignon, J. E. Guidotti, S. Besnard, M. Fabre, N. Duverger, D. Parlier, A. Tedgui, A. Kahn, and H. Gilgenkrantz
Therapeutic liver repopulation in a mouse model of hypercholesterolemia
Hum. Mol. Genet., July 1, 2000; 9(11): 1597 - 1602.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.